Stockreport

Revance Therapeutics: A New Contender In The Botox Arena [Seeking Alpha]

Revance Therapeutics, Inc.  (RVNC) 
Last revance therapeutics, inc. earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.revance.com
PDF Summary Pipeline & Upcoming Catalysts Revance’s ( RVNC ) lead product is RT002, a proprietary peptide formula that contains no human or animal-base [Read more]